A comparison of surgical devices for grade II and III hemorrhoidal disease. Results from the LigaLongo Trial comparing transanal Doppler-guided hemorrhoidal artery ligation with mucopexy and circular stapled hemorrhoidopexy by A. Venara et al.
A comparison of surgical devices for grade II and III
hemorrhoidal disease. Results from the LigaLongo Trial
comparing transanal Doppler-guided hemorrhoidal artery
ligation with mucopexy and circular stapled
hemorrhoidopexy
Submitted by Beatrice Guillaumat on Tue, 01/22/2019 - 13:55
Titre
A comparison of surgical devices for grade II and III hemorrhoidal disease. Results
from the LigaLongo Trial comparing transanal Doppler-guided hemorrhoidal artery
ligation with mucopexy and circular stapled hemorrhoidopexy
Type de
publication Article de revue
Auteur
Venara, Aurélien [1], Podevin, Juliette [2], Godeberge, Philippe [3], Redon, Yann [4],
Barussaud, Marie-Line [5], Sielezneff, Igor [6], Queralto, Michel [7], Bourbao, Cecile
[8], Chiffoleau, Anne [9], Lehur, Paul A [10]
Organisme LigaLongo Study Group [11]
Editeur Springer Verlag








revue International journal of colorectal disease
ISSN 1432-1262
Mots-clés
Adult [12], Arteries [13], Digestive System Surgical Procedures [14], Hemorrhoids




PURPOSE: Little is presently known on the impact of device type for Doppler-guided
hemorrhoidal artery ligation/mucopexy (DGHAL) or circular stapled
hemorrhoidopexy (CSH) when a surgical treatment is considered for hemorrhoidal
disease (HD). In this study, we aimed to compare the outcome in terms of adverse
events and recurrence rate, of patients included in the multicenter LigaLongo RCT (
ClinicalTrials.gov NCT01240772) according to the type of devices used.
METHODS: In the DGHAL arm (N = 193), the procedure was done with transanal
hemorrhoidal dearterialization (THD)™ (THD, Correggio, Italy) (104 patients) and
with HAL-RAR™ (Agency for Medical Innovations (AMI) GmbH, Feldkirch, Austria)
(89 patients). In the CSH arm (N = 184), procedure for prolapse and hemorrhoids
(PPH)-03™ (Ethicon Endo-Surgery, Cincinnati OH) and hemorrhoidopexy and
prolapse (HEM)™ (Covidien, Inc.) staplers were used in respectively 106 and 78
cases. Surgery-related morbidity at 90 postoperative days (POD) based on the
Clavien-Dindo procedure-related complication score and clinical outcome in terms of
recurrence and reoperation rate at 12 postoperative months (POM) was collected.
RESULTS: Three hundred and seventy-seven patients were randomized according to
HD grade. In the DGHAL arm, the number of ligations and mucopexies was higher in
the AMI group (p < 0.0001); at 90 POD, the overall morbidity was similar between
the two groups. In the CSH arm, donut sizes were similar; at 90 POD, the PPH group
had a higher risk of postoperative grade 1 morbidity (anal urgency or incontinence)
compared to the HEM group (p = 0.003). At 12 POM, no statistical difference was
found between the two groups of each arm in terms of grade III recurrence or
reoperation.
CONCLUSION: Postoperative morbidity and outcome at 1 year were similar
regardless of the type of devices used. These findings suggest that device type has
little impact on HD treatment results.
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